-
1
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Veröffentlicht in The New England journal of medicine
VolltextArtikel -
2
-
3
-
4
-
5
-
6
-
7
101 Updated analysis of radium-223 dichloride (Ra-223) impact on pain, skeletal-related events (SRE), and survival from the phase 3 randomized trial (ALSYMPCA) in patients with cas...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
8
130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients wit...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
9
-
10
-
11
-
12
Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bo...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20